Japanese Minister Says PMDA Not Excluded From Streamlining Review
This article was originally published in PharmAsia News
Executive SummaryMinister of Administrative Reform Sachio Edano said the nation's pharmaceutical review body - the Pharmaceutical and Medical Device Agency - will be subject to a streamlining review. Edano didn't pinpoint problems within the PMDA, yet said that all administrative agencies are subject to such a review. The minister made the statement during an interview with online journalists. (Click here for more - Japanese language
You may also be interested in...
Progress is being made towards the implementation of the EU’s new patent system, but the UK’s insistence on severing all ties with the European Court could spell the end for its participation.
With a global supply chain and commercial platform, the Viatris entity to be formed by the merger of Mylan and Pfizer’s Upjohn unit wants to be the partner of choice for mid-sized products overlooked by companies focused on blockbusters.
Ongoing launches, relatively stable market conditions and cost-cutting initiatives are producing record profits from Teva’s European operations, president and CEO Kåre Schultz told delegates to a J.P. Morgan Healthcare Conference.